$26.55
▼ -0.0% Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
ENOV: Raising target price to $28.00
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
Overview
52-week range
$21
$37
36% of range
Avg surprise (last 3)
+8.3%
Avg reaction (last 2)
+3.1%
50% positive
Latest IV / EM
80%
EM ±18.4% · $25 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $0.89 | $0.82 | +8.5% | +9.9% | +9.7% | earnings |
| Fri Oct 3, 2025 | Oct 2025 | $-9.99 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.79 | $0.74 | +6.8% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.81 | $0.74 | +9.5% | — | -3.4% | earnings |
| Fri Sep 27, 2024 | Sep 2024 | $-0.58 | — | — | — | — | financials |
| Fri Jun 28, 2024 | Jun 2024 | $-0.34 | — | — | — | — | financials |
| Fri Mar 29, 2024 | Mar 2024 | $-1.32 | — | — | — | — | financials |
| Fri Sep 29, 2023 | Sep 2023 | $-0.05 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.18 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | BMO | $0.79 | $0.79 | 0.0% |
Financials
Income statement (quarterly)
| Metric | Apr 2026 | Dec 2025 | Oct 2025 | Jul 2025 | Apr 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $224M | — | $220M | $230M | $227M | — | $219M | $236M |
| Gross profit | $365M | — | $329M | $335M | $332M | — | $286M | $289M |
| Operating income | $7M | — | $-558M | $-17M | $-47M | — | $-32M | $-44M |
| Net income | $-9M | — | $-571M | $-37M | $-56M | — | $-32M | $-19M |
| EPS (diluted) | $-0.15 | — | $-9.99 | $-0.64 | $-0.98 | — | $-0.58 | $-0.34 |
Balance sheet (quarterly)
| Metric | Apr 2026 | Dec 2025 | Oct 2025 | Jul 2025 | Apr 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $33M | $36M | $34M | $44M | $38M | $48M | $35M | $35M |
| Inventory | $603M | $584M | $614M | $628M | $586M | $547M | $610M | $615M |
| Total current assets | $1.24B | $1.21B | $1.28B | $1.28B | $1.22B | $1.15B | $1.20B | $1.17B |
| Total assets | $3.83B | $3.83B | $4.43B | $5.02B | $4.88B | $4.72B | $5.55B | $5.44B |
| Long-term debt | $1.29B | $1.26B | $1.34B | $1.37B | $1.37B | $1.31B | $1.33B | $1.33B |
| Total liabilities | $2.35B | $2.34B | $2.41B | $2.44B | $2.25B | $2.15B | $2.22B | $2.15B |
| Total equity | $1.48B | $1.49B | $2.02B | $2.58B | $2.62B | $2.56B | $3.33B | $3.29B |